Laura M Bohn

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Molecular Docking

Pain Management

Top Venues

ACS central science

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah J Hill, Nathan Dao, Vuong Q Dang, Edward L Stahl, Laura M Bohn, Ryan A Shenvi
A Route to Potent, Selective, and Biased Salvinorin Chemical Space. ACS central science 9 (8) (2023)
Agnes Acevedo-Canabal, Travis W Grim, Cullen L Schmid, Nina McFague, Edward L Stahl, Nicole M Kennedy, Thomas D Bannister, Laura M Bohn
Hyperactivity in Mice Induced by Opioid Agonists with Partial Intrinsic Efficacy and Biased Agonism Administered Alone and in Combination with Morphine. Biomolecules 13 (6) (2023)
Agnes Acevedo-Canabal, Travis W Grim, Cullen L Schmid, Nina McFague, Edward L Stahl, Nicole M Kennedy, Thomas D Bannister, Laura M Bohn
Hyperactivity in Mice Induced by Opioid Agonists with Partial Intrinsic Efficacy and Biased Agonism Administered Alone and in Combination with Morphine. Biomolecules 13 (6) (2023)
Christina A Brust, Matthew A Swanson, Laura M Bohn
Structural and functional insights into the G protein-coupled receptors: CB1 and CB2. Biochemical Society transactions 51 (4) (2023)
Agnes Acevedo-Canabal, Travis W Grim, Cullen L Schmid, Nina McFague, Edward L Stahl, Nicole M Kennedy, Thomas D Bannister, Laura M Bohn
Hyperactivity in Mice Induced by Opioid Agonists with Partial Intrinsic Efficacy and Biased Agonism Administered Alone and in Combination with Morphine. Biomolecules 13 (6) (2023)
Huiyong Ma, Tarsis Brust, Kevin J Frankowski, Kimberly M Lovell, Michael D Cameron, Laura M Bohn, Jeffrey Aube
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance. ACS chemical neuroscience 13 (8) (2022)
Sophia L Shevick, Stephan M Freeman, Guanghu Tong, Robin J Russo, Laura M Bohn, Ryan A Shenvi
Asymmetric Syntheses of (+)- and (-)-Collybolide Enable Reevaluation of kappa -Opioid Receptor Agonism. ACS central science 8 (7) (2022)
Edward L Stahl, Cullen L Schmid, Agnes Acevedo-Canabal, Cai Read, Travis W Grim, Nicole M Kennedy, Thomas D Bannister, Laura M Bohn
G protein signaling-biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists. Proceedings of the National Academy of Sciences of the United States of America 118 (48) (2022)
Peter Kolb, Terry Kenakin, Stephen P H Alexander, Marcel Bermudez, Laura M Bohn, Christian S Breinholt, Michel Bouvier, Stephen J Hill, Evi Kostenis, Kirill A Martemyanov, Rick R Neubig, H Ongun Onaran, Sudarshan Rajagopal, Bryan L Roth, Jana Selent, Arun K Shukla, Martha E Sommer, David E Gloriam
Community guidelines for GPCR ligand bias: IUPHAR review 32. British journal of pharmacology 179 (14) (2022)
Edward L Stahl, Laura M Bohn
Low Intrinsic Efficacy Alone Cannot Explain the Improved Side Effect Profiles of New Opioid Agonists. Biochemistry (2021)
Xiaoyan Wang, Dongsheng Liu, Ling Shen, Fahui Li, Yongze Li, Lingyun Yang, Tiandan Xu, Houchao Tao, Deqiang Yao, Lijie Wu, Kunio Hirata, Laura M Bohn, Alexandros Makriyannis, Xiaohong Liu, Tian Hua, Zhi-Jie Liu, Jiangyun Wang
A Genetically Encoded F-19 NMR Probe Reveals the Allosteric Modulation Mechanism of Cannabinoid Receptor 1. Journal of the American Chemical Society 143 (40) (2021)
Jo-Hao Ho, Edward L Stahl, Cullen L Schmid, Sarah M Scarry, Jeffrey Aube, Laura M Bohn
G protein signaling-biased agonism at the κ-opioid receptor is maintained in striatal neurons. Science signaling 11 (542) (2018)